Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
Cancer-Drug Stock Jumps 39% on $10.6 Billion GSK Deal. Why It's a Surprise Move.
05:56am, Tuesday, 09'th Jun 2026
GSK is making a tender offer for Nuvalent at $124 a share in cash, a 40% premium to where the stock traded as of Monday's close.
GSK falls as £8bn takeover of Nuvalent is largest deal in a decade
05:39am, Tuesday, 09'th Jun 2026
GSK PLC (LSE:GSK, NYSE:GSK) shares fell 3% after it agreed to acquire US biotechnology company Nuvalent (NASDAQ:NUVL) for $10.6 billion (£8.0 billion),...
London's FTSE 100 falls as GSK slides after Nuvalent deal
05:13am, Tuesday, 09'th Jun 2026
The UK's benchmark FTSE 100 index moved lower on Tuesday, pressured by losses in healthcare giant GSK after the company announced plans to acquire shares of US-based drug developer Nuvalent in a deal
GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down
03:37am, Tuesday, 09'th Jun 2026
U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer portfolio it
GSK agrees $10.6bn Nuvalent takeover to bolster oncology pipeline
02:32am, Tuesday, 09'th Jun 2026
GSK PLC (LSE:GSK, NYSE:GSK) has agreed to acquire US biotechnology company Nuvalent for $10.6 billion (£8.0 billion), adding "immediate" new sales growth opportunities, as well as a trio of advanced
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
02:29am, Tuesday, 09'th Jun 2026
The acquisition is set to give GSK ownership of three drug candidates for lung cancer, two of which are currently under review by the FDA for approval this year.
UK's GSK to buy US-based cancer drugmaker Nuvalent for $10.6 billion
02:04am, Tuesday, 09'th Jun 2026
British drugmaker GSK on Tuesday agreed to acquire U.S.-listed cancer drug developer Nuvalent for $10.6 billion.
GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT
12:31am, Tuesday, 09'th Jun 2026
UK pharmaceutical group GSK is in talks to acquire oncology biotech Nuvalent for more than $9 billion, according to a Financial Times report. The companies have been in discussions with the aim of fin
GSK in talks to buy cancer biotech Nuvalent for more than $9 billion, FT reports
09:15pm, Monday, 08'th Jun 2026
UK pharmaceutical group GSK is in talks to buy cancer drugmaker Nuvalent for more than $9 billion, the Financial Times reported on Monday, citing people familiar wi
Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression
06:16am, Monday, 08'th Jun 2026
Collaboration leverages Engitix's human ECM Platform to identify high-confidence targets for liver fibrosis regression Collaboration leverages Engitix's human ECM Platform to identify high-confidence
Longspur initiates on Gelion with 153p target, saying its battery tech can undercut China
09:13am, Thursday, 04'th Jun 2026
Longspur Research has initiated coverage of Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S), the battery materials company, with a central case valuation of 153p...
FTSE 100 drops amid China banking concerns and falling oil prices
08:57am, Thursday, 04'th Jun 2026
The UK's benchmark FTSE 100 index fell to its lowest level in more than two weeks on Thursday, weighed down by sharp declines in Asia-focused lenders and miners after reports of tighter offshore banki
US bank sees GSK oncology pipeline as major value driver after New York conference
08:57am, Thursday, 04'th Jun 2026
Jefferies has flagged four near-term catalysts in GSK PLC's (LSE:GSK, NYSE:GSK) oncology pipeline following a fireside chat with the pharmaceutical...
US bank sees GSK oncology pipeline as major value driver after New York conference
08:07am, Thursday, 04'th Jun 2026
Jefferies has flagged four near-term catalysts in GSK PLC's (LSE:GSK, NYSE:GSK) oncology pipeline following a fireside chat with the pharmaceutical company's global head of oncology and research and
Gunnison Copper targets resource expansion with new district-wide drill program at flagship Arizona project
04:41am, Thursday, 04'th Jun 2026
Gunnison Copper Corp (TSX:GCU, OTCQB:GCUMF, FRA:3XS0) has announced plans for a district-wide drilling program at its Gunnison copper project, including the...
